Epidemiology and risk factors of fungal pathogens in sepsis: a prospective nationwide multicenter cohort study

Introduction Sepsis is a life-threatening condition, and fungal pathogens are an increasingly important cause, especially in high-risk groups. During COVID-19, fungal co-infections gained significant attention due to their high morbidity…

Continue ReadingEpidemiology and risk factors of fungal pathogens in sepsis: a prospective nationwide multicenter cohort study

Nosocomial lower respiratory tract infections in patients with immunosuppression: a cohort study

Introduction This post-hoc analysis of a multinational ICU study assessed and compared the clinical profiles, microbiological findings, and outcomes of immunosuppressed versus non-immunosuppressed patients with nosocomial lower respiratory tract infections…

Continue ReadingNosocomial lower respiratory tract infections in patients with immunosuppression: a cohort study

Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review

Introduction Effective treatment of sepsis demands not only the prompt administration of appropriate antimicrobials but also precise dosing to enhance patient survival. Adequate dosing ensures therapeutic drug concentrations at the…

Continue ReadingUnderstanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review

Invasive fungal infections in critically ill children: epidemiology, risk factors and antifungal drugs

Introduction Invasive fungal infections (IFIs) pose a significant threat to critically ill children, particularly those with compromised immune systems. Among the most prevalent fungal pathogens are species of Candida, Aspergillus,…

Continue ReadingInvasive fungal infections in critically ill children: epidemiology, risk factors and antifungal drugs